Skip to content
Newswires Newswir.es
Newswires Newswir.es
  • Business
  • World
    • Africa
    • America
    • Europe
  • Health
  • Lifestyle
  • Science
-
  • Business
  • World
    • Africa
    • America
    • Europe
  • Health
  • Lifestyle
  • Science
Subscribe
Close

Search

Bioresorbable Polymers Market to Reach US$ 11.94 Billion by 2034 at 10.5% CAGR
News

Bioresorbable Polymers Market to Reach US$ 11.94 Billion by 2034 at 10.5% CAGR

By Newswires
November 16, 2026 5 Min Read

The Bioresorbable Polymers Market is growing at a strong pace. It was valued at US$ 4.86 billion in 2025. It is projected to reach US$ 11.94 billion by 2034. That works out to a CAGR of 10.5% from 2026 to 2034. These polymers break down inside the body into harmless by-products and are then absorbed. Doctors use them in sutures, implants, scaffolds, and drug carriers.

What Is Driving the Market?

The first driver is the wish to avoid repeat surgery. Bioresorbable polymers break down into non-toxic by-products such as carbon dioxide and water. This removes the need for a second operation to take out hardware. Patients face less trauma, and healthcare systems save money.

The second driver is the rise of minimally invasive surgery. Specialized surgical centers and dedicated orthopedic clinics keep growing. As surgeons adopt advanced procedures, demand for implants that dissolve on their own stays steady.

Get exclusive insights into the Bioresorbable Polymers Market – https://www.theinsightpartners.com/sample/TIPRE00026862

Targeted drug delivery is the third driver. Advances in polymer science have opened the door to localized therapy. Bioresorbable microspheres and release systems are now used in cancer care and in long-term disease management. They deliver medicine in a controlled way over time.

There are challenges too. Production costs are higher than for traditional metals and plastics. Regulatory approval, such as the FDA PMA route, can be long and complex. These materials also need special storage and sterilization.

Which Segment Leads?

By type, the report covers polylactic acid (PLA), polyglycolic acid (PGA), polydioxanone, polycaprolactone (PCL), and others. PLA is the dominant type. It offers versatile mechanical properties and is widely used in bone plates, screws, and 3D printing filaments.

PGA is a high-growth type. It degrades quickly and has high initial tensile strength, so it suits surgical sutures. Polydioxanone is increasingly used in cardiovascular and soft tissue care, where longer support is needed before absorption. PCL breaks down slowly. That makes it a fit for long-term drug delivery and tissue engineering.

By application, the report covers orthopedic devices, drug delivery, and others. Orthopedic devices remain the primary channel. Trauma care and sports medicine benefit from temporary fixation that disappears once healing is done. Drug delivery is the fastest-rising application. It enables controlled-release products that give steady doses without needing device removal.

Which Region Leads?

North America holds the largest global share. The region has advanced healthcare infrastructure, high surgical volumes, and many research hubs. Demand for implants that disappear is rising. 3D-printed implants are also scaling up, and specialty approvals help firms win the trust of providers.

Europe rests on strong medical technology ecosystems in Germany, France, the UK, and Switzerland. Demand for advanced orthopedic care is high, and rules for biocompatible materials are strict. Research there is moving toward specialized tissue engineering scaffolds.

Asia Pacific is the fastest-growing region. China and India act as the main engines for both manufacturing and clinical use. South and Central America, the Middle East, and Africa are emerging markets. They hold many untapped chances for premium medical device and pharmaceutical suppliers. The United States is the most developed single market.

Which Companies Are Prominent?

The report profiles these key players:

  • BMG Incorporated
  • Evonik Industries AG
  • Foster Corporation
  • Ashland Global Holdings Inc.
  • Poly-Med Incorporated
  • REVA Medical, LLC
  • Musashino Chemical Laboratory, Ltd
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Polysciences Inc
  • Bezwada Biomedical LLC

Both global chemical firms and specialized med-tech startups compete here. They stand out through research skills that allow custom polymer blends, and through the ability to clear tough regulatory paths. Many now offer more than raw resin. They supply 3D printing filaments, drug-eluting coatings, and ready-made orthopedic pins.

Two recent moves show the direction. In July 2025, Evonik signed a deal with IMCD, naming it the exclusive European distributor for its RESOMER bioresorbable polymers used in implantable devices. In June 2025, Ashland added more grades to its viatel bioresorbable polymers for medical devices and aesthetic medicine. These grades are used in dental and orthopedic implants, scaffolds, wound healing, and dermal fillers.

Buy the Full Report https://www.theinsightpartners.com/buy/TIPRE00026862

What Is Changing in 2026?

Personalized care is gaining speed. 3D printing now lets makers build scaffolds that match a patient’s own anatomy. This can speed up bone and tissue recovery. It also moves bioresorbable polymers beyond standard sutures.

Tissue engineering and regenerative medicine are growing too. Bioresorbable scaffolds are being used in high-value medical fields, including cardiovascular care. Bioresorbable vascular scaffolds sit at the high-growth, high-margin end of the market, while sutures remain the high-volume base.

Healthcare systems in emerging economies are expanding as well, which creates demand for modern, biocompatible products.

What Are the Investment Opportunities?

The addressable market is projected to reach about US$ 74.48 billion between 2026 and 2034. That shows the scale of the prize for firms with the right products.

3D printing and personalized implants are a clear opening. Tissue engineering is another, especially for firms that can offer smart polymers that help cells grow. Pediatric and geriatric orthopedics also stand out, because implants that dissolve offer a clear benefit there.

Emerging Asia Pacific corridors offer a third path. Partnerships between Western chemical suppliers and Asian medical distributors can open access to China and India, where demand for premium medical devices is rising. The outlook is positive, and players that master degradation control, quality, and regulation are best placed to gain.

Related Reading / Reports

Explore additional research from The Insight Partners covering related materials markets:

  • Bioresorbable Market — covers bioresorbable materials by type and application.
  • Bioplastics Market — covers plastics made from renewable sources.
  • Masterbatch Market — covers additives and colorants used in plastics.
  • Bottle and CSD Grade PET Market — tracks PET used in beverage bottles.

About US:

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken form an integral part of our research methodology and makes the report unique and reliable.

Contact US

If you have any queries about this report or if you would like further information, please contact us:

Phone: +1-646-491-9876

E-mail: [email protected]

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish

Author

Newswires

Follow Me
Other Articles
Power to Gas Market to Reach US$ 112.13 Million by 2033, Driven by Hydrogen Economy Expansion
Previous

Power to Gas Market to Reach US$ 112.13 Million by 2033, Driven by Hydrogen Economy Expansion

Global Reverse Logistics Market is valued at USD 954.9 Billion in 2026.
Next

Global Reverse Logistics Market is valued at USD 954.9 Billion in 2026.

Free weather widget
  • More than 580,000 Australian children subjected to online sexual approaches each year: new research
    More than 580,000 Australian children subjected to online sexual approaches each year: new research
  • Blow Molded Plastic Market to Reach US$ 156.99 Billion by 2034 at 5.78% CAGR
    Blow Molded Plastic Market to Reach US$ 156.99 Billion by 2034 at 5.78% CAGR
  • Casein Market to Reach US$ 5.86 Billion by 2034, Growing at 4.39% CAGR
    Casein Market to Reach US$ 5.86 Billion by 2034, Growing at 4.39% CAGR
  • Calcium Hypochlorite Market to Hit US$ 874.89 Million by 2031 at 5.4% CAGR
    Calcium Hypochlorite Market to Hit US$ 874.89 Million by 2031 at 5.4% CAGR
  • Dried Figs Market Outlook: Reaching US$ 2.43 Billion by 2034 from US$ 1.55 Billion in 2025
    Dried Figs Market Outlook: Reaching US$ 2.43 Billion by 2034 from US$ 1.55 Billion in 2025
Newswires

Newswires (newswir.es) is a central hub for aggregating and distributing press releases from various businesses and organizations.

In the pre-internet era, journalists relied on services like newswires to discover stories. Now, the technology has changed, but PR newswires still play a role in connecting valuable information with journalists and their audiences.

AI Climate Crypto Economy Elections EVs Health Innovation Politics Press Release Space Sports Tech

Categoires

  • Business
  • Health
  • Lifestyle
  • News
  • Science
  • Tech
  • Video
  • World
Copyright 2026 — Newswir.es. All rights reserved.